Lineage Cell (Israel) Today
| BTX Stock | ILS 438.50 37.70 7.92% |
Performance4 of 100
| Odds Of DistressLess than 26
|
Lineage Cell is trading at 438.50 as of the 23rd of April 2024, a -7.92 percent decrease since the beginning of the trading day. The stock's open price was 476.2. Lineage Cell has about a 26 % chance of experiencing some form of financial distress in the next two years of operation and did not have a very good performance during the last 90 trading days. Equity ratings for Lineage Cell Therapeutics are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 23rd of February 2024 and ending today, the 23rd of April 2024. Click here to learn more.
BioTime, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing therapies for the treatment of degenerative diseases in the United States and internationally. BioTime, Inc. was founded in 1990 and is headquartered in Alameda, California. The company has 0 outstanding shares. More on Lineage Cell Therapeutics
Moving against Lineage Stock
| 0.48 | BLRX | BioLine RX | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Lineage Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Lineage Cell's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Lineage Cell or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Co-CEO, Director | Michael West |
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Lineage Cell Therapeutics (BTX) is traded on Tel Aviv Stock Exchange in Israel and employs 76 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 512.15 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Lineage Cell's market, we take the total number of its shares issued and multiply it by Lineage Cell's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Lineage Cell Therapeutics operates under Healthcare sector and is part of Biotechnology industry. The entity has 0 outstanding shares.
Lineage Cell Therapeutics has accumulated about 27.1 M in cash with (30.88 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.18.
Check Lineage Cell Probability Of Bankruptcy
Lineage Stock Price Odds Analysis
What are Lineage Cell's target price odds to finish over the current price? Depending on a normal probability distribution, the odds of Lineage Cell jumping above the current price in 90 days from now is about 44.61%. The Lineage Cell Therapeutics probability density function shows the probability of Lineage Cell stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon Lineage Cell Therapeutics has a beta of -0.8832 suggesting Additionally, lineage Cell Therapeutics has an alpha of 0.3243, implying that it can generate a 0.32 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of Lineage Cell to move above the current price in 90 days from now is about 44.61 (This Lineage Cell Therapeutics probability density function shows the probability of Lineage Stock to fall within a particular range of prices over 90 days) .
Lineage Cell Therapeutics Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Lineage Cell market risk premium is the additional return an investor will receive from holding Lineage Cell long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Lineage Cell. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Lineage Cell's alpha and beta are two of the key measurements used to evaluate Lineage Cell's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 3.99 | |||
| Semi Deviation | 3.71 | |||
| Standard Deviation | 5.49 | |||
| Variance | 30.1 |
Lineage Stock Against Markets
Picking the right benchmark for Lineage Cell stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Lineage Cell stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Lineage Cell is critical whether you are bullish or bearish towards Lineage Cell Therapeutics at a given time. Please also check how Lineage Cell's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Lineage Cell without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Stock Tickers Now
Stock TickersUse high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |
| All Next | Launch Module |
Lineage Cell Corporate Directors
Lineage Cell corporate directors refer to members of a Lineage Cell board of directors. The board of directors generally takes responsibility for the Lineage Cell's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Lineage Cell's board members must vote for the resolution. The Lineage Cell board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Michael Mulroy | Director | Profile | |
| David Schlachet | Independent Director | Profile | |
| Deborah Andrews | Independent Director | Profile | |
| Don Bailey | Director | Profile |
How to buy Lineage Stock?
Before investing in Lineage Cell, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Lineage Cell. To buy Lineage Cell stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Lineage Cell. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Lineage Cell stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Lineage Cell Therapeutics stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Lineage Cell Therapeutics stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Lineage Cell Therapeutics, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Lineage Stock please use our How to Invest in Lineage Cell guide.
Already Invested in Lineage Cell Therapeutics?
The danger of trading Lineage Cell Therapeutics is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Lineage Cell is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Lineage Cell. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Lineage Cell Therapeutics is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Lineage Cell Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Lineage Cell's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Lineage Cell Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Lineage Cell Therapeutics Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Lineage Cell Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Complementary Tools for Lineage Stock analysis
When running Lineage Cell's price analysis, check to measure Lineage Cell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lineage Cell is operating at the current time. Most of Lineage Cell's value examination focuses on studying past and present price action to predict the probability of Lineage Cell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lineage Cell's price. Additionally, you may evaluate how the addition of Lineage Cell to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |